维普中文期刊产品整合服务
9篇 您的检索式:作者名="CHRISTOPHER BA"
    题名 作者 年代 出处 被引量
1NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer显示文摘Klaus Sahora Irene Kuehrer Axel Eisenhut Belgin Akan Claus Koellblinger Peter Goetzinger Bela Teleky Raimund Jakesz Markus Peck-Radosavljevic Ahmed Ba’ssalamah Christoph Zielinski Michael Gnant 2011Surgery2011,,3:2
2The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria显示文摘Elizabeth MH Wellington Alistair BA Boxall Paul Cross Edward J Feil William H Gaze Peter M Hawkey Ashley S Johnson-Rollings Davey L Jones Nicholas M Lee Wilfred Otten Christopher M Thomas A Prysor Williams 2013The Lancet Infectious Diseases2013,,2:1
3Myocardial insulin resistance induced by high fat feeding in heart failure is asso- ciated with preserved contractile function 显示文摘Christopher BA Huang HM Berthiaume JM 2010Am J Physiol Heart Circ Physiol2010,299,6:1
4Myocardial insulin resistance induced by high fat feeding in heart failure is associated with preserved contractile function显示文摘CHRISTOPHER BA HUANG HM BERTHIAUME JM 2010Am J Physiol Heart Circ Physiol2010,299,6:1
5Extrahepatic Bile Duct Adenocarcinoma: Patients at High-Risk for Local Recurrence Treated with Surgery and Adjuvant Chemoradiation Have an Equivalent Overall Survival to Patients with Standard-Risk Treated with Surgery Alone显示文摘Yerko Borghero MD Christopher H. Crane MD Janio Szklaruk MD Mauricio Oyarzo MD Steven Curley BS MD Peter W. Pisters MD Douglas Evans BS MD Eddie K. Abdalla MD Melanie B. Thomas BA MS MD Prajnan Das MD Ignacio I. Wistuba MD Sunil Krishnan MD Jean-Nicol 2008Annals of Surgical Oncology2008,,11:1
6Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily显示文摘Christophe H Stephane C Magali BA 2007J Hepatology2007,46,5:1
7Long-Term Survival after Resection for Primary Hepatic Carcinoid Tumor显示文摘Clayton D. Knox BA Christopher D. Anderson MD Laura W. Lamps MD R. Benton Adkins MD C. Wright Pinson MD MBA 2003Annals of Surgical Oncology2003,,10:1
8Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivu- dine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil10 mg daily 显示文摘Christophe H Stephane C Magali BA 2007J Hepatology2007,46,5:1
9依据清创术后细菌培养结果确定开放骨折创面关闭时机显示文摘背景:目前,对开放骨折创面缝合关闭的时机尚没有客观的标准。许多学者对于开放骨折创面缝合关闭最佳时机提出了各种各样的建议,但均依据主观评判的参数。本研究的目的是应用前瞻性方法,在四肢开放骨折清创和冲洗木后,依据创面细菌培养结果来指导创面的缝合关闭时机。方法:本组对422例急诊开放骨折患者,进行了创面清创冲洗、骨折固定和开放创面处理。清创术后创面采样进行厌氧菌和有氧菌培养。清创术后48h,患者再次手术。如果初次细菌培养结果为阳性,则再次进行冲洗和清创术,之后再次留取菌培样本。创面不关闭直到细菌培养结果为阴性为止,否则重复进行冲洗和清创术。结果:在422例开放骨折中,有346例获得了长期随访。全组创面深部感染率为4|3%。GustiloⅡ型开放骨折创面深部感染率为4%,GustiloⅢ型开放骨折为5.7%。在GustiloⅢ型开放骨折中,依骨折类型不同,感染率出现变化,GustiloⅢA型开放骨折为1.8%,GustiloⅢB型开放骨折为10.6%,GustiloⅢC型开放骨折为20%。需要反复清创的骨折患者,伴有糖尿病患者以及体重指数增加的患者,感染率均出现上升。研究数据表明,开放骨折在菌培阳性条件下关闭创面(违反本研究原则)并未显著增加深部感染风险(p=0.0501)。结论:采用本文提出的标准处理方法,与历史对照方法相比,开放骨折深部感染率降到很低。但取得这样结果是以增加冲洗和清创术次数为代价。可信水平:治疗性研究Ⅳ级。关于证据等级的完整描述详见投稿须知。Christopher J. Lenarz, MD J. Tracy Watson, MD Berton R. Moed, MD Heidi Israel, PhD, RN J. Daniel Mullen MSPH, BA, BS James B. MacDonald, BS 叶伟胜(译) 2011中华骨科杂志2011,31,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费